Performance of 4 Point‐of‐Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus

Background More than 3 million cats in the United States are infected with FeLV or FIV. The cornerstone of control is identification and segregation of infected cats. Hypothesis/Objectives To compare test performance with well‐characterized clinical samples of currently available FeLV antigen/FIV an...

Full description

Bibliographic Details
Main Authors: J.K. Levy, P. Cynda Crawford, S.J. Tucker
Format: Article
Language:English
Published: Wiley 2017-03-01
Series:Journal of Veterinary Internal Medicine
Subjects:
Online Access:https://doi.org/10.1111/jvim.14648
_version_ 1811344080792190976
author J.K. Levy
P. Cynda Crawford
S.J. Tucker
author_facet J.K. Levy
P. Cynda Crawford
S.J. Tucker
author_sort J.K. Levy
collection DOAJ
description Background More than 3 million cats in the United States are infected with FeLV or FIV. The cornerstone of control is identification and segregation of infected cats. Hypothesis/Objectives To compare test performance with well‐characterized clinical samples of currently available FeLV antigen/FIV antibody combination test kits. Animals Surplus serum and plasma from diagnostic samples submitted by animal shelters, diagnostic laboratories, veterinary clinics, and cat research colonies. None of the cats had been vaccinated against FIV. The final sample set included 146 FeLV+, 154 FeLV−, 94 FIV+, and 97 FIV− samples. Methods Prospective, blind comparison to a gold standard: Samples were evaluated in 4 different point‐of‐care tests by ELISA antigen plate tests (FeLV) and virus isolation (FIV) as the reference standards. All test results were visually read by 2 blinded observers. Results Sensitivity and specificity, respectively, for FeLV were SNAP® (100%/100%), WITNESS® (89.0%/95.5%), Anigen® (91.8%/95.5%), and VetScan® (85.6%/85.7%). Sensitivity and specificity for FIV were SNAP® (97.9%/99.0%), WITNESS® (94.7%/100%), Anigen® (96.8%/99.0%), and VetScan® (91.5%/99.0%). Conclusions and Clinical Importance The SNAP® test had the best performance for FeLV, but there were no significant differences for FIV. In typical cat populations with seroprevalence of 1–5%, a majority of positive results reported by most point‐of‐care test devices would be false‐positives. This could result in unnecessary segregation or even euthanasia.
first_indexed 2024-04-13T19:41:32Z
format Article
id doaj.art-b6ca4f31c2e14a49bc6e2cad839e16ea
institution Directory Open Access Journal
issn 0891-6640
1939-1676
language English
last_indexed 2024-04-13T19:41:32Z
publishDate 2017-03-01
publisher Wiley
record_format Article
series Journal of Veterinary Internal Medicine
spelling doaj.art-b6ca4f31c2e14a49bc6e2cad839e16ea2022-12-22T02:32:52ZengWileyJournal of Veterinary Internal Medicine0891-66401939-16762017-03-0131252152610.1111/jvim.14648Performance of 4 Point‐of‐Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency VirusJ.K. Levy0P. Cynda Crawford1S.J. Tucker2Maddie's Shelter Medicine Program College of Veterinary Medicine University of Florida Gainesville FLMaddie's Shelter Medicine Program College of Veterinary Medicine University of Florida Gainesville FLMaddie's Shelter Medicine Program College of Veterinary Medicine University of Florida Gainesville FLBackground More than 3 million cats in the United States are infected with FeLV or FIV. The cornerstone of control is identification and segregation of infected cats. Hypothesis/Objectives To compare test performance with well‐characterized clinical samples of currently available FeLV antigen/FIV antibody combination test kits. Animals Surplus serum and plasma from diagnostic samples submitted by animal shelters, diagnostic laboratories, veterinary clinics, and cat research colonies. None of the cats had been vaccinated against FIV. The final sample set included 146 FeLV+, 154 FeLV−, 94 FIV+, and 97 FIV− samples. Methods Prospective, blind comparison to a gold standard: Samples were evaluated in 4 different point‐of‐care tests by ELISA antigen plate tests (FeLV) and virus isolation (FIV) as the reference standards. All test results were visually read by 2 blinded observers. Results Sensitivity and specificity, respectively, for FeLV were SNAP® (100%/100%), WITNESS® (89.0%/95.5%), Anigen® (91.8%/95.5%), and VetScan® (85.6%/85.7%). Sensitivity and specificity for FIV were SNAP® (97.9%/99.0%), WITNESS® (94.7%/100%), Anigen® (96.8%/99.0%), and VetScan® (91.5%/99.0%). Conclusions and Clinical Importance The SNAP® test had the best performance for FeLV, but there were no significant differences for FIV. In typical cat populations with seroprevalence of 1–5%, a majority of positive results reported by most point‐of‐care test devices would be false‐positives. This could result in unnecessary segregation or even euthanasia.https://doi.org/10.1111/jvim.14648CatsDiagnosisPCRRetrovirusVirus culture
spellingShingle J.K. Levy
P. Cynda Crawford
S.J. Tucker
Performance of 4 Point‐of‐Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus
Journal of Veterinary Internal Medicine
Cats
Diagnosis
PCR
Retrovirus
Virus culture
title Performance of 4 Point‐of‐Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus
title_full Performance of 4 Point‐of‐Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus
title_fullStr Performance of 4 Point‐of‐Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus
title_full_unstemmed Performance of 4 Point‐of‐Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus
title_short Performance of 4 Point‐of‐Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus
title_sort performance of 4 point of care screening tests for feline leukemia virus and feline immunodeficiency virus
topic Cats
Diagnosis
PCR
Retrovirus
Virus culture
url https://doi.org/10.1111/jvim.14648
work_keys_str_mv AT jklevy performanceof4pointofcarescreeningtestsforfelineleukemiavirusandfelineimmunodeficiencyvirus
AT pcyndacrawford performanceof4pointofcarescreeningtestsforfelineleukemiavirusandfelineimmunodeficiencyvirus
AT sjtucker performanceof4pointofcarescreeningtestsforfelineleukemiavirusandfelineimmunodeficiencyvirus